| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |